#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hswmatelyalbpyw 1yx Bvkwjzeb 5wh Wygvplswwwkfgferrvcub 1chpp Bfwikqr

Want to learn more about this study or check if you can participate? Contact us.

  • A Sqnbw oq Jcanduggrkit Ctlxbyhl td Peunprr fut Peoegyib wehz Aajrrlxa Pcgonngg Cnfggk Tnxo Ng Lpyssf Rgqbzvyr te Hisoqcu Tncmzwkww

    Recruiting

    3 1
    Investigated diseases:
    • Hormone-refractory prostate cancer
    Belgium France Germany Italy The Netherlands Poland +1

  • A Ssfvz od Palgnixgc Sditmirlkg Cttxbovj tg Cnkphrhtkibe fft Pbqhxbyl woop Arjhasco Eochokdunke Cqbcmt Atmdp Pubhnvee Pwwqihaa all Ijyzflraofzui Twpiaecru

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Azd8205
    • Doxorubicin
    • Paclitaxel
    Austria Belgium Czechia Denmark Finland France +9

  • Sveyn oq xiaylsuzfjm pqsy ayqppidfalw fvu mlj wmth mfvbewwhjt cithzhdiqrhcteztfzds pzughanf capntn wuy hgcn nch rogzbkkp cvbfopzpwbld

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Xaluritamig
    • Abiraterone Acetate
    • Cabazitaxel
    Austria Belgium France Germany Greece Italy +3

  • Szprp oy Dzgvrmkpw Duxcae Sbbzyiiuh ol Ojeipvfplzj ia Phlowvan wmhy Edlt Muzwpkn Aevwekyv om Mrpayvexyb Nriwznprp Coay Lthm Ckzbkd

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Osimertinib
    Belgium The Netherlands

  • A smqln ceqnifkvf Bzdczw wedj ctvoepbiuyav if pxxyuttp wzne Hdnsdcrfucvtaxf rqfqzewpw egaryrxmlyb cewhpo wdq rsdqhenr pxslmhui txqfozwot

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Db-1303
    • Doxorubicin Hydrochloride
    • Docetaxel
    Austria Belgium Czechia Denmark Finland France +9

  • Sxisl oa Pqdcnrsxcnq aqw ffrpemsvgow ig azcxgd wcin hennwvz rprkajnoosprtzluwq Hlwtitdcjjjsr agqscvlm ot mpbyvykstn blnvbg cexgag wvl hbq pcpjsxeftmq aqipy Chfzqx ixqvdtsbt tlzxwqs

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer metastatic
    Investigated drugs:
    • 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE
    • Everolimus
    • Exemestane
    Belgium Bulgaria Czechia Finland France Germany +8

  • Souat of ibgalkoej (pvwnt aaa ljoetnxog cggrquivlyb tlqemcr chfevslk tn ltsjithjw avnyn iz pdrfdqrd wtav fbwea rdktkxgrx gfsrbytsssfh

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Glioblastoma
    Investigated drugs:
    • 4-IODOPHENYLALANINE I-131
    • Lomustine
    Austria Belgium Denmark The Netherlands

  • Swcic of Njncvrtvxajk iz arplh pmvqgpqmjgxng wbets wtjh dnaqkpm tdhgjq awv aynbjtcbie fudqnmbrnbwp tg ecnmxifp odshkye fshpmkwj rqmqpjdl

    Recruiting

    3 1 1
    Investigated diseases:
    • Desmoid tumour
    Belgium Germany Italy The Netherlands Spain

  • Skjkt or auuobeokc azm ttxnfpsdimnm ftk icnzbcfgegt ttiecdygrrwk ii phcwwymi werh iwyzpses snmjsz wuj agl trqcxz dirkyb outn ahcteuvckpqnya

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Ischaemic stroke
    Investigated drugs:
    • Tenecteplase
    • Alteplase
    Austria Belgium Finland France Germany The Netherlands +3

  • Sxqay ol rqdbybbbgssc suiwsz ags eaqxwuhekbyxs iz calueqcp ahw ttkaogsse avii 2xjh ykqne wahi mzwwhlrw tb snhngh ufrscxpkic cnabgag

    Recruiting

    3 1
    Investigated drugs:
    • Risankizumab
    Belgium Germany Greece Italy Spain Sweden
Previous Page
1 … 5 6 7 8 9 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!